Clinical Trial Update: Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia [NA]

View source ↗

Summary

A trial evaluating yttrium-90 radioembolization for cirrhosis-associated thrombocytopenia was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Thrombocytopenia

Drugs mentioned

• Yttrium-90 radioembolization (yttrium-90 microspheres)

Snippet

Sponsor: Northwestern University | Conditions: Thrombocytopenia, Cirrhosis | NA | Status: TERMINATED | Results posted: 2025-02-03